Ross Robin D

2 articles in GJC

Long-Term Decrease in Intraocular Pressure in Survivors of Ebola Virus Disease in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Study.

Mudalegundi Shwetha, Ross Robin D, Larbelee Jemma, Amegashie Fred, Dolo Robert F, Prakalapakorn Grace S et al.

Ophthalmol SciNov 20222 citationsCohort Study

Ebola survivors showed a sustained, long-term decrease in intraocular pressure over five years compared to controls. This highlights persistent ocular sequelae of emerging infectious diseases.

Full abstract PubMed

Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study.

Eghrari Allen O, Shantha Jessica G, Ross Robin D, Ryn Collin Van, Crozier Ian, Hayek Brent et al.

Transl Vis Sci TechnolJan 202113 citationsClinical Trial

Cataract surgery in Ebola survivors was safe and effective, with no detectable intraocular virus. Persistent inflammation highlights the need for follow-up, informing surgical guidelines for this population.

Full abstract PubMed

All 2 articles loaded

Global Search

Ross Robin D

Long-Term Decrease in Intraocular Pressure in Survivors of Ebola Virus Disease in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Study.

Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study.